>>Description of the research protocol "EMIT AF/VTE"

EMIT-AF/VTE: Edoxaban management in diagnostic and therapeutic procedures.
Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Cardiologie
Brugmann identifier : EMIT AF/VTE
EudraCT identifier : B322201732873
ClinicalTrials.gov identifier : NCT02950168


Involved department : Cardiology
Principal investigator : Catez
Sponsor : Daichi
Contact : Clinical Research Unit

>This protocol was approved by the KU Leuven ethics committee.